Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders
Abstract Background Neuropathic pain in neuroimmunological disorders refers to pain caused by a lesion or disease of the somatosensory system such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). MS and NMOSD are autoimmune disorders of the central nervous system, and ≥...
Guardado en:
Autores principales: | Kenichi Serizawa, Haruna Tomizawa-Shinohara, Shota Miyake, Kenji Yogo, Yoshihiro Matsumoto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5166acfc575a4ea69619f6a0bc5b9d14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuromyelitis Optica (NMO) in Children: A Rare Case Report
por: Dodik Tugasworo, et al.
Publicado: (2020) -
SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
por: Collin Jugler, et al.
Publicado: (2021) -
Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
por: Suárez H,Felipe, et al.
Publicado: (2016) -
No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang Ting-Ting, et al.
Publicado: (2016) -
The Association between Asphyxia and Interleukin (IL)-6 and IL-1β Levels in Neonates
por: Nenden Nursyamsi Agustina, et al.
Publicado: (2021)